Understand peptides.Share experiences.

Promotes angiogenesis and growth factor signaling (VEGF) that supports tissue repair.

Synthetic variant of Thymosin Beta-4 that regulates actin and promotes cell migration.

GLP-1 receptor agonist that increases insulin secretion, slows gastric emptying and reduces appetite.

Dual GIP and GLP-1 receptor agonist.

ACTH analog that increases BDNF expression and modulates dopamine/serotonin.

Tuftsin analog that modulates the GABA system and immune signaling.

Copper-binding tripeptide that stimulates collagen and modulates gene expression.

Selective ghrelin receptor agonist that triggers growth hormone pulses.

Tripeptide from α-MSH that inhibits NF-κB signaling.

Triple agonist of GLP-1, GIP and glucagon receptors, increasing energy expenditure and reducing appetite.

Combines BPC-157 (angiogenesis, growth factor signaling) with TB-500 (actin regulation, cell migration) for complementary repair.

GHK-Cu (collagen, gene modulation) combined with BPC-157 and TB-500 for tissue repair and skin quality.

GLOW blend plus KPV, adding NF-κB inhibition for an extra anti-inflammatory effect.

GHRH analog that extends growth hormone release; often combined with Ipamorelin.

Stabilized GHRH analog that stimulates pituitary GH release.

Fragment of natural GHRH (1-29) that stimulates GH release.

Mitochondria-derived peptide that activates AMPK and improves glucose utilization.

Tetrapeptide reported to activate telomerase and regulate melatonin.

Melanocortin receptor agonist (MC3R/MC4R) acting centrally on sexual desire.

Non-selective melanocortin agonist that stimulates melanin production.

Modified fragment of growth hormone (176-191) targeting fat breakdown without affecting IGF-1.

Modulates T-cell function and the innate immune response.

Delta sleep-inducing peptide thought to modulate sleep architecture and stress hormones.

Long-acting amylin analog that increases satiety; combined with semaglutide in CagriSema.

Potent ghrelin receptor agonist with strong GH release; may raise cortisol and prolactin.

Ghrelin receptor agonist that releases GH and markedly increases appetite.

Ghrelin receptor agonist with strong GH release and moderate appetite effect.

Human cathelicidin antimicrobial peptide that disrupts microbial membranes and modulates immunity.

Activates the KISS1 receptor, stimulating GnRH and downstream LH/FSH release.

Targets cardiolipin in the inner mitochondrial membrane, stabilizing energy production.

Neuropeptide hormone acting on oxytocin receptors in the brain and uterus.

Angiotensin IV analog that potentiates HGF/c-Met signaling and synapse formation.

Short tripeptide reported to regulate gene expression in brain cells.

EPO-derived peptide that activates the innate repair receptor (EPOR/CD131) without stimulating red blood cell production.

Thymus-derived peptide complex reported to normalize T-cell function.

Mitochondria-derived peptide that protects cells from stress and apoptosis.

Synthetic GnRH that stimulates LH and FSH release from the pituitary.

Binds and inhibits myostatin and activin, removing a brake on muscle growth.

Long-acting IGF-1 analog with reduced binding to IGF binding proteins.

Pegylated mechano growth factor, an IGF-1 splice variant that activates muscle stem cells.

Dual GLP-1 and glucagon receptor agonist.

Dual glucagon and GLP-1 receptor agonist with strong effects on liver fat.

Vasoactive intestinal peptide that relaxes smooth muscle and dampens immune responses.

Disrupts the FOXO4–p53 interaction, pushing senescent cells into apoptosis.